Your session is about to expire
← Back to Search
Liposomal bupivacaine for Sternotomy
Study Summary
This trial is testing a new longer-acting local anesthetic to see if it is more effective than the standard in managing pain after surgery that involves opening the sternum.
- Sternotomy
- Pain Management
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently taking opioids at home for a long period of time.You have a lump or growth on the front part of your ribcage or breastbone.You had a previous surgery where your chest was opened.You have an ongoing pain condition before the study.You have an infection in your breastbone that was there before the trial started.You are allergic to any of the ingredients in liposomal bupivacaine or plain bupivacaine.
- Group 1: Liposomal bupivacaine
- Group 2: Bupivacaine
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what cases is Bupivacaine administered as a medical treatment?
"Bupivacaine is routinely employed to address perphigus, but has also been known to help individuals suffering from acute nonspecific tenosynovitis, general anesthesia, and lupus erythematosus cell."
How many individuals have enrolled in this research endeavor?
"Affirmative. According to the information displayed on clinicaltrials.gov, this experimental trial is actively recruiting participants and was initially posted October 11th 2017 with a recent update occurring twelve days ago. 80 volunteers are needed from one medical facility for the study's completion."
Have any other medical studies utilized Bupivacaine as an active agent?
"At present, 109 research projects related to bupivacaine are underway. Of these tests, 18 have progressed to the advanced phase 3 stage. Trials for this drug can be found at 144 different medical sites located primarily in Philadelphia, Pennsylvania."
Share this study with friends
Copy Link
Messenger